Birth defects among infants born to women who received anthrax vaccine in pregnancy

American Journal of Epidemiology

Volumn 168, Issue 4, 2008, Pages 434-442

  Ryan, Margaret A K ^a   Smith, Tyler C ^a   Sevick, Carter J ^a   Honner, William K ^a   Loach, Rosha A ^a   Moore, Cynthia A ^b   Erickson, J David ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Anthrax vaccines; Congenital abnormalities; Immunization; Military personnel; Reproductive history; Women's health

Indexed keywords

ANTHRAX VACCINE;

ANTHRAX; COHORT ANALYSIS; COMPARATIVE STUDY; DATABASE; DECISION MAKING; DISABILITY; HEALTH IMPACT; IMMUNIZATION; MILITARY GOVERNMENT; MULTIVARIATE ANALYSIS; PREGNANCY; REGRESSION ANALYSIS; REPRODUCTIVE HEALTH; TERRORISM; VACCINATION; VACCINE;

ARMY; ARTICLE; BIRTH DEFECT; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INFANT; MALE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; VACCINATION;

ADULT; ANTHRAX VACCINES; BIOTERRORISM; CHI-SQUARE DISTRIBUTION; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; LOGISTIC MODELS; MATERNAL AGE; MILITARY PERSONNEL; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY TRIMESTERS; PRENATAL CARE; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; UNITED STATES; VACCINATION;

NORTH AMERICA; UNITED STATES;

EID: 49449096153     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn159     Document Type: Article

References (44)

1. Jernigan DB, Raghunathan PL, Bell BP, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002;8:1019-28.
2. Doolan DL, Freilich DA, Brice GT, et al. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics. J Infect Dis 2007;195:174-84.
3. Centers for Disease Control and Prevention. Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. JAMA 2002;288:2681-2.
4. Notice to readers: occupational health guidelines for remediation workers at Bacillus anthracis-contaminated sites - United States, 2001-2002. MMWR Morb Mortal Wkly Rep 2002;51:786-9.
5. Wade N. US seeks anthrax vaccine for almost a million people. New York Times. October 31, 2001.
6. Brookmeyer R, Johnson E, Bollinger R. Public health vaccination policies for containing an anthrax outbreak. Nature 2004;432:901-4.
7. Wein LM, Craft DL, Anthrax Modeling Working Group. Evaluation of public health interventions for anthrax: a report to the Secretary's Council on Public Health Preparedness. Biosecur Bioterror 2005;3:348-56.
8. Weiss MM, Weiss PD, Weiss JB. Anthrax vaccine and public health policy. Am J Public Health 2007;97:1945-51.
9. Friedlander AM, Pittman PR, Parker GW. Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. JAMA 1999;282:2104-6.
10. US General Accounting Office. Medical readiness: DoD continues to face challenges in implementing its anthrax vaccine immunization program. Washington, DC: General Accounting Office, 2000. (http://www.fas.org/spp/starwars/gao/ nsiad-00-157.htm).
11. Staudenmeier JJ, Bacon BL, Ruiz RT, et al. Anthrax refusers: a 2nd infantry division perspective. Mil Med 2003;168:520-2.
12. Fowler GL, Baggs JM, Weintraub ES, et al. Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program. Pharmacoepidemiol Drug Saf 2006;15:880-8.
13. Sever JL, Brenner AI, Gale AD, et al. Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiol Drug Saf 2004;13:825-40.
14. Grabenstein JD. Anthrax vaccine: a review. Immunol Allergy Clin North Am 2003;23:713-30.
15. Joellenbeck LM, Zwanziger LL, Durch JS, et al, eds. The anthrax vaccine: is it safe? Does it work? Washington, DC: National Academies Press, 2002.
16. Wiesen AR, Littell CT. Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among US Army women. JAMA 2002;287:1556-60.
17. Catherino WH, Levi A, Kao TC, et al. Anthrax vaccine does not affect semen parameters, embryo quality, or pregnancy outcome in couples with a vaccinated male military service member. Fertil Steril 2005;83:480-3.
18. Surveillance for adverse events associated with anthrax vaccination - US Department of Defense, 1998-2000. MMWR Morb Mortal Wkly Rep 2000;49:341-5.
19. Honner WK, Ryan MAK, Aran R, et al. The US military immunization database: quality of data on anthrax immunizations in military women, 1998-2000. Presented at the 4th Immunization Registry Conference, Atlanta, Georgia, October 27-29, 2003.
20. Payne DC, Rose CE Jr, Aranas A, et al. Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004. Pharmacoepidemiol Drug Saf 2007;16:605-11.
21. Ryan MAK, Pershyn-Kisor MA, Honner WK, et al. The Department of Defense Birth Defects Registry: overview of a new surveillance system. Teratology 2001;64(suppl 1):S26-9.
22. National Birth Defects Prevention Network. Birth defects surveillance data from selected states, 1999-2003. Birth Defects Res A Clin Mol Teratol 2006;76:835-960.
23. Correa-Villasenor A, Cragan J, Kucik J, et al. The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Res A Clin Mol Teratol 2003;67:617-24.
24. Notice to readers: status of US Department of Defense preliminary evaluation of the association of anthrax vaccination and congenital anomalies. MMWR Morb Mortal Wkly Rep 2002;51:127.
25. Zeger SL, Liang KY. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
26. Sato PA, Reed RJ, Smith TC, et al. Monitoring anthrax vaccine safety in US military service members on active duty: surveillance of 1998 hospitalizations in temporal association with anthrax immunization. Vaccine 2002;20:2369-74.
27. Wells TS, Sato PA, Smith TC, et al. Military hospitalizations among deployed US service members following anthrax vaccination, 1998-2001. Hum Vaccin 2006;2:54-9.
28. Carmichael SL, Shaw GM, Nelson V. Timing of prenatal care initiation and risk of congenital malformations. Teratology 2002;66:326-30.
29. Ryan MAK, Gumbs GR, Conlin AMS, et al. Evaluation of preterm births and birth defects in liveborn infants of US military women who received smallpox vaccine. Birth Defects Res A Clin Mol Teratol (DOI: 10.1002/bdra.20470).
30. Grabenstein JD. Pregnancy and lactation in relation to vaccines and antibodies. Pharm Pract Manag Q 2001;20:1-10.
31. Munoz FM, Englund JA. Vaccines in pregnancy. Infect Dis Clin North Am 2001;15:253-71.
32. Bridges CB, Fukuda K, Cox NJ, et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2001;50(RR-4):1-44.
33. Czeizel AE, Rockenbauer M. Tetanus toxoid and congenital abnormalities. Int J Gynaecol Obstet 1999;64:253-8.
34. Shields KE, Galil K, Seward J, et al. Varicella vaccine exposure during pregnancy: data from the first 5 years of the pregnancy registry. Obstet Gynecol 2001;98:14-19.
35. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Recomm Rep 2001;50(RR-12):1-23.
36. Cavalcanti DP, Salomão MA, Lopez-Camelo J, et al. Early exposure to yellow fever vaccine during pregnancy. Trop Med Int Health 2007;12:833-7.
37. Ryan MA, Seward JF, Smallpox Vaccine in Pregnancy Registry Team. Pregnancy, birth, and infant health outcomes from the National Smallpox Vaccine in Pregnancy Registry, 2003-2006. Clin Infect Dis 2008;46(suppl 3):S221-6.
38. Holladay SD, Sharova L, Smith BJ, et al. Nonspecific stimulation of the maternal immune system. I. Effects on teratogen-induced fetal malformations. Teratology 2000;62:413-19.
39. Yitzhakie D, Torchinsky A, Savion S, et al. Maternal immunopotentiation affects the teratogenic response to hyperthermia. J Reprod Immunol 1999;45:49-66.
40. Anderson RH, Brown NA, Webb S. Development and structure of the atrial septum. Heart 2002;88:104-10.
41. Takami T, Kawashima H, Kamikawa A, et al. Characteristics of 11 neonates with atrial septal defects detected by heart murmurs. Am J Perinatol 2003;20:195-9.
42. Bruckner T, Catalano R. The sex ratio and age-specific male mortality: evidence for culling in utero. Am J Hum Biol 2007;19:763-73.
43. Gold EB, Tomich E. Occupational hazards to fertility and pregnancy outcome. Occup Med 1994;9:435-69.
44. Women with smallpox vaccine exposure during pregnancy reported to the National Smallpox Vaccine in Pregnancy Registry - United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:386-8.